Rigel Pharmaceuticals | RIGL - Ebit





Ebit Cambio Fecha
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
MacroGenics USD -12.1M 32.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12